共 130 条
- [1] Pai VB(2001)Efficacy and safety of aerosolized tobramycin in cystic fibrosis Pediatr Pulmonol 32 314-27
- [2] Nahata MC(1999)Management of patients with cystic fibrosis: defining the role of inhaled tobramycin Dis Manag Health Outcomes 6 93-108
- [3] Lamb HM(2002)Nebulized antibiotics in cystic fibrosis [published erratum appears in Pediatr Drugs 2003; 5 (1): 40] Paediatr Drugs 4 455-67
- [4] Goa KL(2001)Cystic fibrosis Thorax 56 237-41
- [5] Sermet-Gaudelus I(1996)Management of pulmonary disease in patients with cystic fibrosis [published erratum appears in N Eng J Med 1996 Oct; 335 (15): 1167] N Engl J Med 335 179-88
- [6] Le Cocguic Y(1997)Antimicrobial treatment of pulmonary colonization and infection by J Antimicrob Chemother 40 468-74
- [7] Ferroni A(1998) in cystic fibrosis patients Infect Dis Clin Pract 7 66-79
- [8] Robinson P(1994)Aerosolized antibiotics for bacterial lower airway infections: principles, efficacy, and pitfalls Pediatr Pulmonol 17 331-9
- [9] Ramsey BW(1997)Nebulizer delivery of tobramycin to the lower respiratory tract Chest 111 955-62
- [10] Denton M(1989)A comparison of peak sputum tobramycin concentration in patients with cystic fibrosis using jet and ultrasonic nebulizer systems. Aerosolized Tobramycin Study Group Pediatr Pulmonol 7 265-71